ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 170 out of 6645

$1.82M Total Retail Price of All Prescriptions

Rank: 103 out of 6645

437 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 18,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$94 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ATELVIA 1,086 1,059 10 1 91
CRESTOR 974 919 2 34
AMLODIPINE BESYLATE 899 817 3 2
CLOPIDOGREL 648 609 4 36
AMOXICILLIN 605 553 10 5 107
DIOVAN 545 525 6 19
ATENOLOL 499 471 7 8
PLAVIX 455 432 8 49
CARVEDILOL 438 412 9 25
SIMVASTATIN 435 345 10 1
OMEPRAZOLE 405 372 11 6
PATANOL 383 345 12 131
GLIMEPIRIDE 317 297 13 47
CELEBREX 314 301 14 54
ZOLPIDEM TARTRATE 303 286 15 17
BENICAR 296 280 16 84
METFORMIN HCL 296 267 16 7
ALENDRONATE SODIUM 276 260 18 14
EXFORGE 272 252 19 155
ATORVASTATIN CALCIUM 261 237 20 10
LOSARTAN POTASSIUM 249 230 21 12
COREG CR 247 242 22 242
SINGULAIR 244 233 23 76
NEXIUM 242 226 24 40
KOMBIGLYZE XR 234 222 10 25 297
AZITHROMYCIN 234 227 25 44
LIDODERM 230 224 27 53
TAMSULOSIN HCL 212 197 28 22
MELOXICAM 208 193 29 46
GABAPENTIN 199 187 30 18
FLUOCINONIDE 176 169 31 130
MOMETASONE FUROATE 174 170 32 292
ZENPEP 168 167 33 210
CLONIDINE HCL 164 148 34 56
MONTELUKAST SODIUM 160 150 35 128
SYMBICORT 154 140 36 153
LIVALO 143 133 37 274
LIPITOR 138 116 38 69
AZOR 134 134 39 152
TRIAMCINOLONE ACETONIDE 118 116 40 55
METOPROLOL TARTRATE 116 104 41 13
EFFIENT 114 112 42 261
IBANDRONATE SODIUM 105 104 43 147
ENALAPRIL MALEATE 95 70 44 75
CREON 94 94 45 114
LISINOPRIL 94 76 45 3
CIPROFLOXACIN HCL 94 84 45 67
EXELON 93 93 48 149
JENTADUETO 91 85 10 49 642
COLCRYS 89 71 50 192
DONEPEZIL HCL 89 89 50 27
ACIPHEX 88 76 52 167
DEXILANT 88 88 52 102
JANUVIA 87 87 54 38
DIPHENOXYLATE-ATROPINE 87 75 54 214
MECLIZINE HCL 86 84 56 122
ISOSORBIDE MONONITRATE ER 85 85 57 66
VYTORIN 81 73 58 170
PATADAY 79 75 59 183
ENABLEX 78 78 60 301
THEOPHYLLINE ANHYDROUS 78 73 60 253
LOPERAMIDE 78 75 60 281
MICARDIS 71 57 63 232
PANTOPRAZOLE SODIUM 69 69 64 29
RANITIDINE HCL 68 66 65 51
TRICOR 66 53 66 138
EVISTA 64 40 67 90
LOVAZA 62 59 68 68
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 69 97
TRAMADOL HCL 60 52 70 30
NASONEX 60 51 70 126
LANTUS SOLOSTAR 58 58 72 139
GLYBURIDE 58 46 R 72 58
RESTASIS 58 54 72 311
CYPROHEPTADINE HCL 54 53 R 75 472
HYDROCODONE-ACETAMINOPHEN 53 49 S3 76 5
LEVOTHYROXINE SODIUM 52 36 77 4
CYCLOBENZAPRINE HCL 51 45 R 78 157
TRIBENZOR 50 50 79 257
FUROSEMIDE 50 47 79 11
BENICAR HCT 50 50 79 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.